Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Abacus Bioscience
AddedFeb 17, 2024
UpdatedJun 18, 2026
Abacus Bioscience

Abacus Bioscience

Seed

Abacus Bioscience: Pioneering immunotherapies for chronic diseases and cancers since 2017.

HQ
Seattle, WA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Abacus Bioscience, founded in 2017 and headquartered in Seattle, Washington, is dedicated to developing innovative immunotherapies for chronic infectious diseases and cancers. The company's core mission is to extend the immunotherapy frontier by creating first-in-class active immunotherapies that overcome immune tolerance. Abacus Bioscience offers a versatile platform capable of integrating with various cancer and viral antigens, aiming to provide effective treatments for a wide range of chronic conditions.

Notable figures affiliated with Abacus Bioscience include leading scientists and industry experts in immunotherapy and biotechnology. The company has attracted significant investment from prominent venture capital firms specializing in healthcare innovation. Key achievements include the development of experimental drugs with structures predicted by advanced technologies like AlphaFold. Abacus Bioscience's impact lies in its potential to revolutionize the treatment landscape for chronic infections and cancers, offering hope to patients worldwide.

Abacus Bioscience - Similar Companies

ABio-X logo

ABio-X

abio-x.com

Therabiol logo

Therabiol

Asher Bio logo

Asher Bio

asherbio.com

Scribe Biosciences logo

Scribe Biosciences

3T Biosciences logo

3T Biosciences

3tbiosciences.com

SAB Biotherapeutics logo

SAB Biotherapeutics

sab.bio

Arbutus Biopharma logo

Arbutus Biopharma

arbutusbio.com

Abintus Bio logo

Abintus Bio

abintusbio.com

AltruBio logo

AltruBio

Inimmune logo

Inimmune

inimmune.com

Adaptive Biotechnologies logo

Adaptive Biotechnologies

HI-Bio logo

HI-Bio

hibio.com

Abreos Biosciences logo

Abreos Biosciences

abreos.com

Larkspur Biosciences logo

Larkspur Biosciences

larkspur.bio

Cartography Biosciences logo

Cartography Biosciences

cartography.bio

Abacus Bioscience - Quick Facts

Who are Abacus Bioscience's competitors?

Companies similar to Abacus Bioscience include ABio-X, Therabiol, Asher Bio and Scribe Biosciences.

When was Abacus Bioscience founded?

Abacus Bioscience was founded in 2017.

Where is Abacus Bioscience's headquarters located?

Abacus Bioscience's headquarters is located in Seattle, WA, US.

When was Abacus Bioscience's last funding round?

Abacus Bioscience's most recent funding round was for $4.4M (USD) in February 2023.

How much has Abacus Bioscience raised to-date?

As of Feb 1, 2023, Abacus Bioscience has raised a total of $4.4M (USD).

How many employees does Abacus Bioscience have?

Abacus Bioscience has 2 employees as of Feb 5, 2024.

Abacus Bioscience - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immunotherapy
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified